Stocks and Investing Stocks and Investing
Fri, May 4, 2018
Thu, May 3, 2018

Raghuram Selvaraju Initiated (BTAI) at Strong Buy and Held Target at $25 on, May 3rd, 2018


Published on 2024-10-26 05:19:15 - WOPRAI, Raghuram Selvaraju
  Print publication without navigation


Raghuram Selvaraju of HC Wainwright & Co., Initiated "BioXcel Therapeutics, Inc." (BTAI) at Strong Buy and Held Target at $25 on, May 3rd, 2018.

Raghuram has made no other calls on BTAI in the last 4 months.



There are 2 other peers that have a rating on BTAI. Out of the 2 peers that are also analyzing BTAI, 0 agree with Raghuram's Rating of Hold.



These are the ratings of the 2 analyists that currently disagree with Raghuram


  • Colin Bristow of "UBS" Initiated at Strong Buy and Held Target at $18 on, Monday, April 2nd, 2018
  • Geoff Meacham of "Barclays" Initiated at Buy and Held Target at $15 on, Monday, April 2nd, 2018

Contributing Sources